(26 Mar 2021) TenofovirDF- may be an effective antiviral in the treatment of COVID-19
Tenofovir-DF versus Hydroxychloroquine in the Treatment of Hospitalized Patients with COVID-19: An Observational Study (TEDHICOV) https://www.medrxiv.org/content/10.1101/2021.03.24.21252635v1 NCT04812496- 104 patients were included: 36 in the HCQ group and 68 in the TDF group. The unadjusted primary outcomes were: LOS (length of… Continue reading "(26 Mar 2021) TenofovirDF- may be an effective antiviral in the treatment of COVID-19"